Z6_M9M2H1K0NOLR30AVT6L64K2040
{"Z7_M9M2H1K0NOLR30AVT6L64K20I3":{"windowState":"normal","portletMode":"view"},"Z7_GILIHB01N04000QQC0UE352GI2":{"windowState":"normal","portletMode":"view"}}
Z7_M9M2H1K0NOLR30AVT6L64K20I3
Nobivac Edge DAPPv+L4 - 25x1 Dose
INV157474
Nobivac EDGE DAPPv+L4 is a 0.5 mL combo vaccine that provides parainfluenze protection in combination with four-way leptospirosis protection.
- Aids in the prevention of disease, mortality, and leptospiriuria caused by four Leptospira serovars
- 0.5 mL combination vaccine formula to include parainfluenza
- Protects against all known strains of canine parvovirus (CPV), including CPV-2c
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides CPV maternal antibodies in young puppies
- Systemic administration stimulates a strong IgG response (CPiV)
- Protects against adenovirus type 1 that causes hepatitis in dogs
Safety & Quality
- 99% Reaction Free: out of 1,583 doses given in Clinical Impressions study
- Lower total protein level than other 0.5 ml vaccine options
- Onderstepoort-type strain in Nobivac® vaccines provides a high level of safety (CDV)
- A porous filtration membrane selectively removes extraneous proteins, salts, and solvents
- Fewer total proteins (TP) means a more purified final product, which may reduce unwanted immune system responses such as vaccine reactions
- Promotes a higher level of vaccine quality
- Same process used for Nobivac® Lepto4, Nobivac®Canine-1 DAPPv+L4, and Nobivac EDGE™ Lepto4
Related Documents
INV157474
Nobivac Edge DAPPv+L4 - 25x1 Dose
/PennVet Catalog/TX - Product Categories/88 - Vaccines/7 - Vaccines/1 - Canine/3 - Combo No Corona with Lepto
/PennVet Catalog/TX - Manufacturers/MERCK - Merck Animal Health
Product Detail Page
Z7_GILIHB01N04000QQC0UE352GI2